MRI Contrast Agent Leads to Metal Buildup in Patients
A study highlights that MRI contrast agents containing gadolinium can cause harmful metal buildup in some patients, raising concerns about safety and long-term effects, especially given the lack of FDA-approved antidotes for gadolinium retention. The discussion emphasizes the importance of informed consent, understanding risks, and the need for further research into the safety of these agents.